TrialNature communications2024

Adjuvant dendritic cell therapy in stage IIIB/C melanoma: the MIND-DC randomized phase III trial.

Kalijn F Bol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.